Research Site 1229 — Wilmington, North Carolina

Research Site 1229 is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site 1229 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Theracos.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 1229?

Research Site 1229 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 1229 conducted?

Research Site 1229 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Research Site 1229 accredited by Crixeo Health?

Research Site 1229 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 1229?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.